zm 241385 has been researched along with cannabidiol in 3 studies
| Studies (zm 241385) | Trials (zm 241385) | Recent Studies (post-2010) (zm 241385) | Studies (cannabidiol) | Trials (cannabidiol) | Recent Studies (post-2010) (cannabidiol) |
|---|---|---|---|---|---|
| 401 | 3 | 124 | 3,279 | 321 | 2,646 |
| Protein | Taxonomy | zm 241385 (IC50) | cannabidiol (IC50) |
|---|---|---|---|
| Cholinesterase | Equus caballus (horse) | 0.67 | |
| Heat sensitive channel TRPV3 | Rattus norvegicus (Norway rat) | 0.75 | |
| Transient receptor potential cation channel subfamily A member 1 | Rattus norvegicus (Norway rat) | 0.45 | |
| Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 3.7 | |
| Transient receptor potential cation channel subfamily M member 8 | Rattus norvegicus (Norway rat) | 2.8 | |
| Transient receptor potential cation channel subfamily V member 4 | Rattus norvegicus (Norway rat) | 5.9 | |
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerman, Z; Avraham, Y; Berry, EM; Magen, I; Mechoulam, R; Vorobiev, L | 1 |
| Akamine, AT; Almeida, VI; Crippa, JA; Dal-Pizzol, F; Ferraz-de-Paula, V; Hallak, JE; Mariano-Souza, DP; Palermo-Neto, J; Pinheiro, ML; Quevedo, J; Quinteiro-Filho, WM; Ribeiro, A; Vitoretti, LB; Zuardi, AW | 1 |
| Carrillo-Salinas, FJ; Feliú, A; Guaza, C; Iñigo, PM; Mecha, M; Mestre, L | 1 |
3 other study(ies) available for zm 241385 and cannabidiol
| Article | Year |
|---|---|
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.
Topics: Adenosine A2 Receptor Antagonists; Animals; Bile Ducts; Brain-Derived Neurotrophic Factor; Cannabidiol; Chronic Disease; Cognition; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Female; Gait Disorders, Neurologic; Hepatic Encephalopathy; Ligation; Liver Diseases; Mice; Mice, Inbred Strains; Motor Activity; Receptor, Adenosine A2A; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Treatment Outcome; Triazines; Triazoles | 2009 |
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor.
Topics: Acute Lung Injury; Adenosine A2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Bronchoalveolar Lavage Fluid; Cannabidiol; Cannabinoids; Capillary Permeability; Chemokines; Cytokines; Disease Models, Animal; Drug Evaluation, Preclinical; Leukocytes; Male; Mice; Mice, Inbred C57BL; Peroxidase; Receptor, Adenosine A2A; Triazines; Triazoles | 2012 |
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
Topics: Animals; Brain; Cannabidiol; Cardiovirus Infections; Cell Adhesion; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Disease Models, Animal; Endothelial Cells; Inflammation; Interleukin-1beta; Mice; Motor Activity; Multiple Sclerosis; Receptor, Adenosine A2A; Triazines; Triazoles; Vascular Cell Adhesion Molecule-1 | 2013 |